Market Value311,575,076
Total Holdings53
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ORIC / ORIC Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
INSM / Insmed Incorporated
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
GHRS / GH Research PLC
IFRX / InflaRx N.V.
SWTX / SpringWorks Therapeutics, Inc.
SION / Sionna Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc. Put
BPMC / Blueprint Medicines Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RVMD / Revolution Medicines, Inc.
FOLD / Amicus Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
CGON / CG Oncology, Inc.
OCUL / Ocular Therapeutix, Inc.
SLDB / Solid Biosciences Inc.
MLYS / Mineralys Therapeutics, Inc. Put
EWTX / Edgewise Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc. Call
NBIX / Neurocrine Biosciences, Inc.
ABUS / Arbutus Biopharma Corporation
DYN / Dyne Therapeutics, Inc.
MRK / Merck & Co., Inc. Call
CYTK / Cytokinetics, Incorporated
ARQT / Arcutis Biotherapeutics, Inc. Call
XENE / Xenon Pharmaceuticals Inc.
RYTM / Rhythm Pharmaceuticals, Inc. Call
SYRE / Spyre Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
ELVN / Enliven Therapeutics, Inc.
CVS / CVS Health Corporation Put
BBC / ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF Call
QURE / uniQure N.V.
RYTM / Rhythm Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
SRZN / Surrozen, Inc.
IMVT / Immunovant, Inc. Call
SNDX / Syndax Pharmaceuticals, Inc.
TSHA / Taysha Gene Therapies, Inc.
PCSC / Perceptive Capital Solutions Corp
KALV / KalVista Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
ALKS / Alkermes plc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
TARA / Protara Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
MDGL / Madrigal Pharmaceuticals, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ARQT / Arcutis Biotherapeutics, Inc.
JANX / Janux Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc.
BHVN / Biohaven Ltd.
EYPT / EyePoint Pharmaceuticals, Inc.
TECX / Tectonic Therapeutic, Inc.
MLYS / Mineralys Therapeutics, Inc.
DNLI / Denali Therapeutics Inc.
WVE / Wave Life Sciences Ltd.
ACLX / Arcellx, Inc.
MRUS / Merus N.V.
GERN / Geron Corporation
SRRK / Scholar Rock Holding Corporation
MBX / MBX Biosciences, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
VTGN / Vistagen Therapeutics, Inc.
HLXB / Helix Acquisition Corp. II
IDYA / IDEAYA Biosciences, Inc.
IMVT / Immunovant, Inc.
APGE / Apogee Therapeutics, Inc.
LENZ / LENZ Therapeutics, Inc.
ROIV / Roivant Sciences Ltd.
ROIV / Roivant Sciences Ltd. Call
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock) Call
GERN / Geron Corporation Call
PTGX / Protagonist Therapeutics, Inc.
MNMD / Mind Medicine (MindMed) Inc.
RZLT / Rezolute, Inc.
ADCT / ADC Therapeutics SA
BBIO / BridgeBio Pharma, Inc.
TNGX / Tango Therapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)